A failed clinical trial HIV vaccine that left 46 Zambian women infected with the virus has sparked controversy.

The Microbicides Development Programme (MDP) 301 trial, which was testing if the gel PRO2000 would prevent HIV infection took place between September 2005 and 2009.

It was conducted at six research centres in South Africa, Tanzania, Uganda and Zambia and 9,385 participated.

From the Zambian site in Mazabuka district - about 160 kilometres South West of the capital Lusaka - 1, 332

HIV negative women were recruited but the results, which the Ministry of Health does not wish to comment on, revealed that between 46 and 50 of women that participated in the clinical trial contracted HIV despite using PRO2000 gel before sex.

"Some participants did become HIV positive because the study was conducted in the normal environment," confirmed Dr Maureen Chisembele, principal investigator for Microbicides Development Programme Zambia - a subsidiary of the UK based research entity.

"Women who became infected during the study were given further counselling and referred to local health services for ART (antiretroviral therapy)."

The National Aids Council of Zambia (NAC), a government unit mandated to oversee HIV/Aids programme, confirmed that 50 out of the 1, 332 women that participated in the clinical trials contracted HIV.

Due to the sensitivity and repercussions of the issue, the Ministry of Health has remained tight-lipped on the outcome of the trials.

A vaginal microbicide is a product intended for use before sexual intercourse to reduce HIV infection and they are supposed to be used with condoms and complement other prevention strategies such as behaviour change, abstinence and other preventive methods.

It should be noted that vaginal microbicide should not be used alone or replace correct and consistent use of condoms in the fight against HIV and Aids, said Dr Swebby Macha - a gynaecologist at Zambia's University Teaching Hospital (UTH) in Lusaka, the largest hospital in the country.

The participants in the clinical trial were either assigned the PRO2000 gel or placebo gel (with inactive ingredient) and were instructed to apply gel about one hour before sexual intercourse.

The gel contains molecules that are intended to cluster around the virus before it can penetrate the vaginal wall.

To be effective, the women were counselled on safe sexual behaviour and encouraged to use condoms, which were provided free of charge.

According to Dr Macha, this clinical trial found that the risk of HIV infection in women that were supplied with PRO2000 gel was not significantly different than women supplied with placebo gel.

"The largest international clinical trial to date into a preventive HIV gel has found no evidence that the vaginal microbicide, PRO2000, reduces the risk of HIV infection in women," said Dr Macha, the former president of Zambia Medical Association (ZMA).

Dr Macha said to date no microbicide had been proved to be effective against HIV infection.

A local traditional ruler has demanded compensation for the infected women and prosecution of architects of the clinical trial.

Chief Mwanachingwala of the Tonga people in Mazabuka district where the clinical trials took place said the women that took part in the trials were "poor and uneducated" and did not know the consequences of the research, which has left some of them infected.

But Ministry of Health officials, speaking on anonymity basis, argued that MDP followed the laid down legal and clinical procedures, therefore, were not liable to prosecution over the outcome of clinical trials.

In an explanatory statement, Dr Chisembele said that during the clinical trial, a lot of emphasis was put on the fact that it was unknown whether PRO2000 gel would work to prevent HIV.

The infection of the 46 women has drawn outrage from many Zambians who are accusing MDP of using some African women as "guinea pig" because they are poor and ignorant.

Zambia is among African countries hardest hit by Hiv infections with prevalence rate of 14.3 per cent of its population estimated at about 13 million people.

Trial HIV Vaccine Leaves 46 Zambian women Infected

Somali Press

 A study published in the journal Breast Cancer Research and Treatment has found that women overwhelmingly reject the breast cancer prevention drug tamoxifen even when given a thorough, personalized analysis of its risks and benefits. University of Michigan researchers administered the information about the drug to 632 women and found that only one percent of participants actually ended up taking it.

A 13-year-old girl living in the United Kingdom has been suffering from early-onset dementia since the age of nine, according to British news reports.

The Natural Products Association (NPA) and the Council for Responsible Nutrition (CRN) have both voiced outrage over the publication of “Cancer Incidence and Mortality after Treatment with Folic Acid and Vitamin B12” in the 11/19/09 issue of JAMA.

 If you listen to political talk-radio, you may have been puzzled by recent ads about seeds. Why would anyone be concerned about access to seeds? Because approximately 82 percent of the global seed supply is patented and owned by a handful of big corporations.

 When it comes to selling chemicals that claim to treat H1N1 swine flu, the pharmaceutical industry's options are limited to two: Vaccines and anti-virals. The most popular anti-viral, by far, is Tamiflu, a drug that's actually derived from a Traditional Chinese Medicine herb called star anise.

 A supplement of the amino acid N-acetylcysteine may ease the symptoms of compulsive hair pulling, according to a study conducted by researchers from the Minnesota School of Medicine and published in the Archives of General Psychiatry.

  A British epidemiologist said on Tuesday he was worried by close links between World Health Organization (WHO) officials and pharmaceutical companies over swine flu.

Scientists from the University of Cincinnati's psychiatry department carried out a study which involved 12 people with early memory loss drinking pure 100 per cent Concord grape juice for 12 weeks.

Breckenridge High School student suspended and assaulted by teachers for informing fellow students as to the dangers associated with the H1N1 vaccine and vaccines in general.